abrysvo: Clinical Trials

3 trials of abrysvo, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 not yet recruiting, 1 recruiting. 3 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 33Completed 1, Not yet recruiting 1, Recruiting 1

Follow abrysvo: new trials by email Literature Review of abrysvo trials Research Report on abrysvo

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Prevention of RSV Infection in Infants by Administering Nirsevimab to Infants, With or Without Maternal RSV Vaccination
Nirsevimab, Abrysvo - RSV Immunization
Phase 3RecruitingCentre Hospitalier Annecy Genevois10002026-05-062026-05-27
Pregnancy and Infant PrEparedness pLatform IN Europe, RSV-International Adaptive Platform Trial to Evaluate Two Approved Prevention Options to Prevent Respiratory Syncytial Virus in Infants: Maternal Vaccine to Women in Pregnancy and Monoclonal Antibody to the Infants, Given Alone or in Combination.
Abrysvo, Nirsevimab - RSV Immunization
Phase 3Not yet recruitingPENTA Foundation15002025-09-012025-06-27
A Study to Evaluate the Safety and Immunogenicity of RSVpreF Coadministered With Herpes Zoster Vaccine in Adults
RESPIRATORY SYNCYTIAL VIRUS PREFUSION F SUBUNIT VACCINE, HZ/su VACCINE - Respiratory Syncytial Virus (RSV)
Phase 3CompletedPfizer5262025-04-042025-11-06

Conditions studied

Respiratory Tract Infections (1)

Sponsors

Centre Hospitalier Annecy Genevois (1)  ·  PENTA Foundation (1)  ·  Pfizer (1)

Countries

France (1)  ·  Puerto Rico (1)  ·  United States (1)

Top investigators

Pierre Frange (1)

NIH funding

2025 (2)